Candriam Equities L Oncology Impact R-H/ LU1864483083 /
| NAV06.06.2024 | Diff.+0.6500 | Ertragstyp | Ausrichtung | Fondsgesellschaft |
|---|---|---|---|---|
| 194.0700EUR | +0.34% | thesaurierend | Aktien weltweit | Candriam ▶ |
Monatliche Performance
| Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez | Gesamt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | - | - | - | - | - | - | - | - | - | - | - | 3.80 | - |
| 2022 | -10.61 | -1.92 | 4.33 | -6.01 | -1.54 | -0.31 | 4.18 | -3.41 | -5.17 | 6.64 | 5.71 | -3.82 | -12.68% |
| 2023 | 1.90 | -4.09 | 1.15 | 2.65 | -2.80 | -0.13 | 0.71 | -2.23 | -5.41 | -6.53 | 8.95 | 5.51 | -1.42% |
| 2024 | 1.23 | 3.97 | 1.35 | -3.54 | 2.29 | 2.48 | - | - | - | - | - | - | - |
Kennzahlen
| lfd. Jahr | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | |
|---|---|---|---|---|---|
| Volatilität | 10.71% | 10.95% | 11.66% | -% | -% |
| Sharpe Ratio | 1.45 | 2.17 | 0.15 | - | - |
| Bester Monat | +5.51% | +5.51% | +8.95% | +8.95% | - |
| Schlechtester Monat | -3.54% | -3.54% | -6.53% | -10.61% | - |
| Maximaler Verlust | -6.97% | -6.97% | -16.11% | - | - |
| Outperformance | - | - | - | - | - |
Alle Kurse in EUR
Tranchen
| Titel | Ertragstyp | Rückn. Preis | 1 Jahr | 3 Jahre | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | thesaurierend | 2'402.3501 | +8.18% | +4.99% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 2'567.2300 | +8.32% | +5.38% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 207.7400 | +4.62% | -5.87% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 2'235.0200 | +4.75% | +15.35% | |
| Candriam Equities L Oncology Imp... | ausschüttend | 1'611.9800 | +7.83% | +3.98% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 245.2300 | +4.97% | +13.24% | |
| Candriam Equities L Oncology Imp... | ausschüttend | 236.2600 | +6.82% | +1.10% | |
| Candriam Equities L Oncology Imp... | ausschüttend | 191.3900 | +7.73% | +3.67% | |
| Candriam Equities L Oncology Imp... | ausschüttend | 20'691.0000 | +2.80% | +0.83% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 158.1100 | +4.63% | +14.96% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 2'113.1299 | +5.61% | -3.17% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 259.9500 | +5.87% | +16.14% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 207.1800 | +4.19% | -6.98% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 286.9900 | +7.72% | +3.66% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 194.0700 | +5.49% | - | |
| Candriam Equities L Oncology Imp... | thesaurierend | 1'843.8000 | +5.09% | - | |
| Candriam Equities L Oncology Imp... | thesaurierend | 2'875.2300 | +7.38% | +3.61% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 157.6200 | - | - | |
| Candriam Equities L Oncology Imp... | thesaurierend | 273.5400 | +6.37% | +0.73% |
Performance
| lfd. Jahr | +7.85% | ||
|---|---|---|---|
| 6 Monate | +12.90% | ||
| 1 Jahr | +5.49% | ||
| 3 Jahre | - | ||
| 5 Jahre | - | ||
| 10 Jahre | - | ||
| seit Beginn | -5.78% | ||
| Jahr | |||
| 2023 | -1.42% | ||
| 2022 | -12.68% | ||
